J5C-38918-00935
3 vaccinations
9 coded responses
34 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 836 / ID
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-21
Dose 1 — Moderna
-
2021-01-21
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body achesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Joint painsAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-27
- 2021-01-28
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Survey response — day 21, dose 1MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
-
2021-02-20
Dose 2 — Moderna
- 2021-02-25
- 2021-02-26
- 2021-03-01
- 2021-03-07
- 2021-03-13
-
2021-03-22
Survey response — day 28, dose 2MedDRA: Diarrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: DiarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-08-21
-
2021-12-19
Dose 3 — Moderna
-
2021-12-19
Survey response — day 0, dose 3MedDRA: Dysgeusia, Paraesthesia — Feeling: Fair · Site: Pain, Swelling, Itching · Fever · HeadacheFree text: Tingling, metallic tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-12-21
Report sent to call center — days 1–6 daily, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-22
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tirednessFree text: Swollen lymphnodesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · HeadacheAdult check-in
-
2021-12-23
Call successfulCompleted over the phone
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-12-26
- 2022-01-02
- 2022-01-09
-
2022-01-16
Survey response — day 28, dose 3MedDRA: Headache, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache nauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-23
Survey response — day 35, dose 3MedDRA: Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: SickMedDRA releases: 2024-11 · check-in free text available
- 2022-01-31
- 2022-03-20
-
2022-06-19
Survey response — 6 months, dose 3MedDRA: Headache, Rhinorrhoea — Feeling: FairFree text: Runny nose and headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-12-19
Survey response — 12 months, dose 3MedDRA: Headache, Medical counselling, Pyrexia, Respiratory tract irritation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Headache, chest irritation, fever · Healthcare visit (other): In home urgent care visitMedDRA releases: 2024-11 · check-in free text available
-
2022-12-19
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-20 | Moderna | |
| 3 | 2021-12-19 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 3 — day 14, dose 1
Symptoms: Dizziness
Release 4 — day 21, dose 1
Symptoms: Headaches
Release 6 — day 28, dose 2
Symptoms: Diarrhea
Release 10 — day 0, dose 3
Systemic reaction (other): Tingling, metallic taste
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymphnodes
Release 10 — day 28, dose 3
Symptoms: Headache nausea
Release 11 — day 35, dose 3
Symptoms: Sick
Release 12 — 6 months, dose 3
Symptoms: Runny nose and headache
Release 12 — 12 months, dose 3
Symptoms: Headache, chest irritation, fever
Healthcare visit (other): In home urgent care visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract irritation | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Dysgeusia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release